Wyss InstituteTherapeutics – Wyss Institute

David Walt named as laureate for National Medal of Technology and Innovation

Jessica Leff — Tue, 07 Jan 2025 14:52:56 +0000

By Benjamin Boettner (BOSTON) — On January 3, Wyss Institute Core Faculty member David Walt, Ph.D., who also is a Professor of Pathology at Boston’s Brigham and Women’s Hospital (BWH), the Hansjörg Wyss Professor of Biologically Inspired Engineering at Harvard Medical School (HMS), an Associate member at the Broad Institute, and a Howard Hughes Medical Institute Professor…

Source

SeqVerify: A New Easily Accessible Tool for Comprehensive Cell Line Quality Assessment – The Stem Cell Report

Jessica Leff — Thu, 12 Dec 2024 16:54:17 +0000

During the last decade, advances in genome editing and pluripotent stem cell (PSC) culture have let researchers generate edited PSC lines to study a wide variety of biological questions. However, abnormalities in cell lines such as aneuploidy, mutations, on-target and off-target editing errors, and microbial contamination can arise during PSC culture or due to undesired editing outcomes.

Source

Wyss Institute’s iNodes team receives ARPA-H Sprint for Women’s Health award to advance the first implantable immune organs to treat ovarian cancer

Jessica Leff — Tue, 12 Nov 2024 14:58:41 +0000

By Benjamin Boettner (BOSTON) — Ovarian cancer is more deadly than any other type of female reproductive organ cancer. It is estimated that in 2024, in the U.S. alone, more than 12,000 women will die from the disease because available therapies are not effective. To help overcome this striking deficit in women’s health, ARPA-H has selected a team at the Wyss Institute at Harvard University as…

Source

Injectable Hydrogel Adhesive for Improved Muscle Regeneration

Jessica Leff — Wed, 06 Nov 2024 14:30:59 +0000

Although it was only given a clinical definition in 2010, volumetric muscle loss (VML) has been a persistent problem in medicine for centuries. VML can be caused by injuries, diseases, and some surgical procedures like removing a tumor, and results in so much damage to a muscle that its function is permanently compromised, leading to long-term disability. There is currently no effective treatment…

Source

CRISPR’s Impact, Today

Mariel Schoen — Mon, 21 Oct 2024 12:00:08 +0000

By Seth Kroll (BOSTON) — In the not-so-distant past, CRISPR, the revolutionary gene-editing technology, was discovered as a defense system protecting bacteria against viruses. Today, with the persistence and ingenuity of many scientists, it is no longer just the subject of fascinating academic research papers and speculative discussions on its future usefulness for medicine.

Source

Kwasi Adu-Berchie named 2024 STAT Wunderkind

Jessica Leff — Wed, 16 Oct 2024 14:11:12 +0000

By Lindsay Brownell (BOSTON) – The Wyss Institute is thrilled to announce that Kwasi Adu-Berchie, Ph.D., a member of the Wyss’ Advanced Technology Team working in Immuno-Materials Platform led by Core Faculty member Dave Mooney, Ph.D., has been named a 2024 STAT Wunderkind by STAT News. The Wunderkinds awards are given annually by STAT News to the next generation of scientific superstars who…

Source

DoriNano – Improved DNA Origami Nanodelivery to Fight Cancer and Other Diseases

Jessica Leff — Fri, 04 Oct 2024 18:20:45 +0000

We’re developing DNA Origami nanodelivery, which is transforming nanoparticle industry. Developed at the Dana Farber Cancer Institute and the Wyss Institute at Harvard University, this innovative approach overcomes the challenges of other nanoparticles, offering stability, high drug loading capacity, nano-scale control of cargo spacing, and more – making it a highly customizable solution for…

Source

Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies

Jessica Leff — Wed, 02 Oct 2024 13:20:13 +0000

By Benjamin Boettner (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Attivare Therapeutics Inc. announced that Attivare has licensed a portfolio of immune-modulating biomaterial technologies from Harvard University that was created at the Wyss Institute, John A. Paulson School of Engineering and Applied Sciences (SEAS)…

Source

“Suspended animation” drug could aid organ transplantation and survival from traumatic injury

Jessica Leff — Tue, 24 Sep 2024 14:50:33 +0000

(CAMBRIDGE, UK) – Researchers have shown that a non-addictive pain relief drug could be used to preserve cells and organs quickly and safely for transplantation, removing the need for static cold storage. The research, published today in eLife, was described by the editors as an important study providing solid evidence that the existing drug, SNC80, can rapidly and reversibly slow biochemical…

Source

Eliz Amar Lewis on Using Many Tools to Fight a Sophisticated Disease

Jessica Leff — Tue, 24 Sep 2024 14:50:19 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Eliz Amar Lewis has always been fascinated by biology. But when she saw her grandmother bravely battle breast cancer, she was inspired to use her passion to develop a smart and sophisticated…

Source